ArticlePediatric nephrology (Berlin, Germany)2020

Rituximab versus cyclophosphamide as first steroid-sparing agent in childhood frequently relapsing and steroid-dependent nephrotic syndrome.

Jameela A Kari et al.PubMed ↗Publisher ↗

No numbers read from the abstract.